All News

2061 articles, sorted by publication time.

New Biomedical Drugs · us

Making surviving retinal cells light-sensitive: Optogenetic therapy planned for a phase 2 geographic atrophy trial

After photoreceptors are lost, can the remaining neural circuits receive light again? Nanoscope plans to seek an answer through a randomized controlled trial. Current supporting evidence comes from a small Stargardt disease study and animal models; the therapy has not yet been shown to improve vision in patients with geographic atrophy.